Episode 300: Adjuvant PD1 Therapy in Solid Tumors

David McDermott discusses the use of ipilimumab and pembrolizumab for melanoma and the similarities between current melanoma trials and kidney cancer treatments.
Dr. McDermott is a professor of medicine at Harvard Medical School and a physician at Beth Israel Deaconess Medical Center.